Alyeska Investment Group’s Oculis Holding OCS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.86M Sell
206,332
-125,000
-38% -$2.84M 0.01% 549
2026
Q1
$8.81M Hold
331,332
0.02% 416
2025
Q4
$6.62M Buy
331,332
+200,000
+152% +$4M 0.02% 433
2025
Q3
$2.31M Hold
131,332
0.01% 508
2025
Q2
$2.55M Hold
131,332
0.01% 476
2025
Q1
$2.5M Buy
+131,332
New +$2.69M 0.01% 409

Other funds holding OCS

Alyeska Investment Group's OCS Position: Q2 2026 in Review

Alyeska Investment Group reduced its Oculis Holding (OCS) stake by 38% in Q2 2026, selling an estimated $2.84M and leaving 206,332 shares worth $2.86M. The position accounts for 0.01% of the portfolio, ranked #549.

Alyeska Investment Group first reported a position in OCS in Q1 2025 and has held it in 6 quarters since. The position peaked at $8.81M in Q1 2026. 59 funds tracked by Wall St. Rank hold OCS as of Q2 2026.

  • Alyeska Investment Group held 206,332 shares of Oculis Holding worth $2.86M as of Q2 2026.
  • Alyeska Investment Group sold 125,000 Oculis Holding shares in Q2 2026, an estimated $2.84M.
  • Oculis Holding made up 0.01% of Alyeska Investment Group's portfolio in Q2 2026, its #549 holding.
  • Alyeska Investment Group first reported a position in Oculis Holding in Q1 2025 and has held it in 6 quarters since.
  • Alyeska Investment Group's Oculis Holding position peaked at $8.81M in Q1 2026.
  • 59 funds tracked by Wall St. Rank held Oculis Holding as of Q2 2026.

Based on Alyeska Investment Group's 13F filing for Q2 2026, filed 14 Aug 2026.